← back to search

David Putnam

Saint Meinrad Seminary and School of Theology · US
Area of research
Molecular Biology · Microbiology
Research interest
Research interests include RNA Interference and Gene Delivery, Advanced biosensing and bioanalysis techniques, Bacterial Infections and Vaccines, and Nanoparticle-Based Drug Delivery.
h-index
43
citations
7,594
works
118
NIH funding
primary concept
email

Recent publications

Synthetic Lubrication of Bone Interfaces for Late-Stage Osteoarthritis Treatment.
2025cited by 0position: contributordoi
A Quantitative Model of Chemotherapeutic Drug Sensitivity as a Function of P-Glycoprotein Expression.
2025cited by 0position: contributordoi
A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens
Nature Communications 2023cited by 79position: middledoi
Selective Accumulation of Near Infrared-Labeled Multivalent Quinidine Copolymers in Tumors Overexpressing P-Glycoprotein: Potential for Noninvasive Diagnostic Imaging.
2023cited by 2position: contributordoi
Biological Nanoparticles in Vaccine Development
Frontiers in Bioengineering and Biotechnology 2022cited by 69position: lastdoi
Imaging optically thick tissues simply and reproducibly: a practical guide to Lightsheet Macroscopy
2022cited by 0position: contributordoi
An amphiphilic polymer for the synthesis of diverse polymer libraries exemplified using conjugates with lower critical solution temperatures that span water's liquid state
Journal of Polymer Science 2021cited by 0position: contributordoi
Induced fusion and aggregation of bacterial outer membrane vesicles: Experimental and theoretical analysis
Journal of Colloid and Interface Science 2020cited by 36position: lastdoi
Induced fusion and aggregation of bacterial outer membrane vesicles: Experimental and theoretical analysis.
2020cited by 30position: contributordoi
Enabling P-glycoprotein inhibition in multidrug resistant cancer through the reverse targeting of a quinidine-PEG conjugate.
2020cited by 19position: contributordoi
Influence of Block Length on Articular Cartilage Lubrication with a Diblock Bottle-Brush Copolymer.
2020cited by 6position: contributordoi
Selective and Tunable Galectin Binding of Glycopolymers Synthesized by a Generalizable Conjugation Method.
2019cited by 16position: contributordoi
Altered Biodistribution and Tissue Retention of Nanoparticles Targeted with P-Glycoprotein Substrates
Regenerative Engineering and Translational Medicine 2019cited by 1position: contributordoi
Immunization with outer membrane vesicles displaying conserved surface polysaccharide antigen elicits broadly antimicrobial antibodies
Proceedings of the National Academy of Sciences 2018cited by 99position: middledoi
Designer outer membrane vesicles as immunomodulatory systems – Reprogramming bacteria for vaccine delivery
Advanced Drug Delivery Reviews 2017cited by 179position: lastdoi
Safe Recombinant Outer Membrane Vesicles that Display M2e Elicit Heterologous Influenza Protection
Molecular Therapy 2017cited by 105position: lastdoi
Recombinant M2e outer membrane vesicle vaccines protect against lethal influenza A challenge in BALB/c mice
Vaccine 2016cited by 140position: lastdoi
Outer membrane vesicles displaying engineered glycotopes elicit protective antibodies
Proceedings of the National Academy of Sciences 2016cited by 138position: middledoi
Synthetic Biomaterials from Metabolically Derived Synthons
Chemical Reviews 2016cited by 76position: lastdoi
Concepts, technologies, and practices for drug delivery past the blood–brain barrier to the central nervous system
Journal of Controlled Release 2015cited by 86position: lastdoi
Microbial biosynthesis of designer outer membrane vesicles
Current Opinion in Biotechnology 2014cited by 94position: middledoi
Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale
Current Opinion in Biotechnology 2013cited by 91position: middledoi

Grants

I-Corps: Viscosupplement for the treatment of osteoarthritis
NSF2331192$50,0002023–2024PIRePORTER
CAREER: An Interdisciplinary Research and Education Program for Predictive Biomaterial Design
NSF0642509$400,0002007–2013PIRePORTER

Frequent collaborators

· 10 papers (2019–2025)Matthew P. DeLisa · Cornell University9 papers (2013–2023)Tyler D. Moeller · United States Naval Medical Research Unit SOUTH3 papers (2016–2023)Hannah C. Watkins · Adimab (United States)3 papers (2016–2017)Joseph Rosenthal · City of Hope3 papers (2013–2016)Linxiao Chen · Cornell University3 papers (2013–2016)Gary R. Whittaker · Cornell University2 papers (2016–2017)Bradley D. Jones · University of Iowa2 papers (2016–2018)Kevin B. Weyant · University of Massachusetts Lowell2 papers (2018–2023)Taylor C. Stevenson · GlaxoSmithKline (India)2 papers (2017–2018)C. Garrett Rappazzo · Adimab (United States)2 papers (2016–2017)Jenny L. Baker · Cornell University2 papers (2013–2014)Cynthia A. Leifer · Cornell University2 papers (2016–2017)Annie Chau · Cornell University2 papers (2016–2017)Aditya Misra · Brigham and Women's Hospital2 papers (2017–2020)Cara Robertus · Cornell University2 papers (2022–2025)Yehou M.D. Gnopo · Cornell University2 papers (2017–2020)Chung‐Jr Huang · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2016–2016)Lindsey Crawford · Cornell University1 papers (2015–2015)Yung‐Fu Chang · Cornell University1 papers (2018–2018)